The remaining three percent of vaccine recipients, 343 people, reported "serious" side effects, the CDC explains. In total, 17 of those were thrombosis with thrombocytopenia syndrome (TTS), including 14 blood clots of the brain called cerebral venous sinus thrombosis (CVST). In looking at the full 13,725 events reported via VAERS, that's a 0.1 percent rate of blood clots. These adverse reactions have primarily been in women under 50, though some have been slightly older and recently, there was a case involving a man. Most occurred within two weeks of receiving the Johnson & Johnson vaccine.
While health officials don't discount the seriousness of these cases, they say the vaccine is largely safe and the benefits greatly outweigh the risks of a rare potentially fatal reaction. When the Johnson & Johnson vaccine pause was lifted, FDA Commissioner Janet Woodcock, MD, said in a statement: "We have concluded that the known and potential benefits of the Janssen COVID-19 vaccine outweigh its known and potential risks in individuals 18 years of age and older."Sandra Fryhofer, MD, the American Medical Association's (AMA) liaison to the CDC's Advisory Committee on Immunization Practices (ACIP), recently spoke about the "rare but serious" risk of blood clots from the Johnson & Johnson vaccine.
"Patients who've had the Janssen vaccine should seek immediate medical attention if they develop shortness of breath, chest pain, leg swelling, persistent abdominal pain, neurological symptoms including severe or persistent headache or blurred vision, or petechiae beyond the site of vaccination," Fryhofer said during a Apr. 26 video update on the AMA website.
And for more health news delivered straight to your inbox, sign up for our daily newsletter.
Article From & Read More ( 97 Percent of Johnson & Johnson Reactions Are 'Nonserious,' CDC Says - msnNOW )https://ift.tt/3u6kY37
Health
Bagikan Berita Ini
0 Response to "97 Percent of Johnson & Johnson Reactions Are 'Nonserious,' CDC Says - msnNOW"
Post a Comment